Lineage Point Capital LP purchased a new stake in GP-Act III Acquisition Corp. (NASDAQ:GPAT – Free Report) during the 4th quarter, HoldingsChannel reports. The fund purchased 65,000 shares of the company’s stock, valued at approximately $695,000.
A number of other large investors have also recently modified their holdings of GPAT. Longfellow Investment Management Co. LLC purchased a new position in shares of GP-Act III Acquisition during the third quarter worth about $83,000. Bank of America Corp DE purchased a new stake in GP-Act III Acquisition in the third quarter valued at approximately $85,000. Clear Street Group Inc. bought a new stake in GP-Act III Acquisition during the third quarter valued at approximately $109,000. Cannon Global Investment Management LLC grew its stake in GP-Act III Acquisition by 38.1% in the 4th quarter. Cannon Global Investment Management LLC now owns 14,500 shares of the company’s stock worth $155,000 after buying an additional 4,000 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC purchased a new position in GP-Act III Acquisition in the 3rd quarter worth approximately $203,000.
Analysts Set New Price Targets
Separately, Weiss Ratings reissued a “sell (d)” rating on shares of GP-Act III Acquisition in a report on Tuesday, April 21st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.
GP-Act III Acquisition Price Performance
Shares of GPAT stock opened at $10.88 on Friday. The business has a 50-day moving average price of $10.88 and a two-hundred day moving average price of $10.79. GP-Act III Acquisition Corp. has a 12-month low of $10.50 and a 12-month high of $12.00.
GP-Act III Acquisition (NASDAQ:GPAT – Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.06 earnings per share (EPS) for the quarter.
GP-Act III Acquisition Company Profile
GP-Act III Acquisition Corp is a special purpose acquisition company organized as a Delaware corporation that completed its initial public offering in 2021. As a blank-check company, it has no commercial operations of its own and was formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
The company’s primary business activity is to identify and acquire a target company in sectors such as technology, business services, healthcare or other high-growth industries.
Featured Articles
- Five stocks we like better than GP-Act III Acquisition
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Want to see what other hedge funds are holding GPAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GP-Act III Acquisition Corp. (NASDAQ:GPAT – Free Report).
Receive News & Ratings for GP-Act III Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP-Act III Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
